Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleR-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma.AuthorsAl-Sarayfi, Diana; Meeuwes, Frederik O.; Durmaz, Müjde; Issa, Djamila E.; Brouwer, Rolf E.; Beeker, Aart; van Rhenen, Anna; Mutsaers, Pim G. N. J.; Böhmer, Lara H.; van der Poel, Marjolein W. M.; te Boome, Liane; van Meerten, Tom; Chamuleau, Martine E. D.; Zijlstra, Josée M.; Brink, Mirian; Nijland, MarcelSubjectsDIFFUSE large B-cell lymphomas; B cell lymphomaPublicationBlood Cancer Journal, 2022, Vol 12, Issue 9, p1ISSN2044-5385Publication typeArticleDOI10.1038/s41408-022-00723-4